Confo Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of CFTX-1554 in Healthy Subjects (NCT05260658) | Confo Therapeutics | 2022-02-09 |
Track Confo Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.